
VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings
Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Newspaper Publication | 2026-05-30 | English | |
| Copy of Newspaper Publication | 2026-05-30 | English | |
| Postal Ballot Notice | 2026-05-29 | English | |
| Shareholders meeting | 2026-05-29 | English | |
| Annual Secretarial Compliance Report | 2026-05-29 | English | |
| Copy of Newspaper Publication | 2026-05-26 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47900311 | Newspaper Publication | 2026-05-30 | English | ||
| 47900238 | Copy of Newspaper Publication | 2026-05-30 | English | ||
| 47888501 | Postal Ballot Notice | 2026-05-29 | English | ||
| 47887376 | Shareholders meeting | 2026-05-29 | English | ||
| 47887846 | Annual Secretarial Compliance Report | 2026-05-29 | English | ||
| 47063350 | Copy of Newspaper Publication | 2026-05-26 | English | ||
| 47062415 | Newspaper Publication | 2026-05-26 | English | ||
| 46825238 | Credit Rating- Others | 2026-05-22 | English | ||
| 46825194 | Update on Credit Rating | 2026-05-22 | English | ||
| 46771397 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-22 | English | ||
| 46771464 | Earnings call Transcript | 2026-05-22 | English | ||
| 46681248 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-20 | English | ||
| 46681082 | Earnings call audio recording | 2026-05-20 | English | ||
| 46651885 | Copy of Newspaper Publication | 2026-05-20 | English | ||
| 46651823 | Copy of Newspaper Publication -Audited Financial results | 2026-05-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
VIYASH SCIENTIFIC LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62287/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62287 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62287 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62287 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62287}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for VIYASH SCIENTIFIC LIMITED (id: 62287)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.